Seroepidemiology of hepatitis B virus infection in Khuzestan Province, Southwest of Iran

Hepatitis Monthly

Volumn 9, Issue 1, 2009, Pages 34-38

  Hajiani, Eskandar ^a   Hashemi, Sayed Jalal ^a   Masjedizadeh, Abuul Rahim ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hepatitis B virus; Iran; Khuzestan; Risk factors; Seroprevalence

Indexed keywords

HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANAMNESIS; ARTICLE; CHILD; CHRONIC HEPATITIS; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; HEPATITIS B; HUMAN; INFECTION RISK; IRAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; QUESTIONNAIRE; RISK FACTOR; SCHOOL CHILD; SEROEPIDEMIOLOGY; SEROLOGY; SEX DIFFERENCE; VIRUS CARRIER;

EID: 67649306444     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11(2):97-107.
2. Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2005;9(2):191-211, v.
3. Alavian SM, Mostajabi P, Malekzadeh R, Azimi K, Vosoogh H, Sarrafi M. Evaluation of Hepatitis B Transmission Risk Factors in Tehran Blood Donors. Govaresh. 2004;9:169-75.
4. Zali MR, Mohammad K, Farhadi A, Masjedi MR, Zargar A, Nowroozi A. Epidemiology of hepatitis B in the Islamic Republic of Iran. East Mediterr Health J. 1996;2:290-8.
5. Alizadeh AHM, Ranjbar M, Ansari S, et al. Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran. Eastern Mediterranean Health Journal. 2006;12(5):528.
6. [Iran's health and disease surveillance report]; 2001 Contract No.: Document Number.
7. Boag F. Hepatitis B: heterosexual transmission and vaccination strategies. Int J STD AIDS. 19912(5):318-24.
8. Alavian SM, Fallahian F, Lankarani KB. Comparison of seroepidemiology and transmission modes of viral hepatitis B in Iran and Pakistan. Hep Mon. 2008;8(1):51-559.
9. Zali MR, Mohammad K, Noorbala AA, Noorimayer B, Shahraz S. Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran. East Mediterr Health J. 2005; 11(1-2):62-7.
10. Alavian SM. Ministry of Health in Iran Is Serious about Controlling Hepatitis B. Hep Mon. 2007;7:3-5.
11. Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am. 1994;23(3):437-55.
12. Sali S, Bashtar R, Alavian SM. Risk Factors in Chronic Hepatitis B Infection: A Case-control Study. Hep Mon. 2005;5:109-15.
13. Nuchprayoon T, Chumnijarakij T. Risk factors for hepatitis B carrier status among blood donors of the National Blood Center, Thai Red Cross Society. Southeast Asian J Trop Med Public Health. 1992; 23(2):246-53.
14. Gogos CA, Fouka KP, Nikiforidis G, et al. Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece. Eur J Epidemiol. 2003;18(6):551-7.
15. Tanaka J. Hepatitis B epidemiology in Latin America. Vaccine. 2000;18 Suppl 1:S17-9.
16. Goubran GF, Cullens H, Zuckerman AJ, Feddleston AL, Williams R. Hepatitis B virus infection in dental surgical practice. Br Med J. 1976;2(6035):559-60.
17. Tzukert A, Sandler SG. Dental care and spread of hepatitis B virus infection. J Clin Microbiol. 1978;8(3):302-5.
18. Roshandel G, Semnani S, Abdolahi N, et al. Prevalence of hepatitis D virus infection in hepatitis B surface antigen-positive subjects in Golestan province, northeast Iran. J Microbiol Immunol Infect. 2008;41(3):227-30.
19. Torabi S, Ebrahim-poor S, Maljaie H, Naqili B. Seroepidemiologic study on hepatitis delta virus among HBsAg positive subjects in Tabriz, Iran. Urmia Med J. 2002;13:290-7.
20. Rezvan H, Forouzandeh B, Taroyan S, Fadaiee S, Azordegan F. A study on delta virus infection and its clinical impact in Iran. Infection. 1990;18(1):26-8.
21. Amini S, Mahmoodi MF, Andalibi S, Solati AA. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study. J Trop Med Hyg. 1993;96(5):277-87.
22. Kawai M, Feinstone S. Acute viral hepatitis. In: Mandell G, Bennett J, Dolin R, editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 5th ed: Churchill Livingstone; 1999. p. 828-1287.
23. Govindarajan S, De Cock KM, Redeker AG. Natural course of delta superinfection in chronic hepatitis B virus-infected patients: histopathologic study with multiple liver biopsies. Hepatology. 1986;6(4):640-4.
24. Rezvan H. Prevalence of e-antigen and antibody among healthy blood donors carrying hepatitis B surface antigen. Irn J Med Sci. 1986;13:44-6.
25. Lok AS, McMahon BJ. Chronic hepatitis B: update of recommendations. Hepatology. 2004;39(3):857-61.
26. Yosefirad M, Malekzadeh R, Khatibian M, Alavian SM. Prospective controlled trial of interferon alpha-2b in Iranian patients with chronic hepatitis B. Gastroenterology. 1997;112:A1420.
27. Chu CJ, Keeffe EB, Han SH, et al. Prevalence of HBV precore/core promoter variants in the United States. Hepatology. 2003; 38(3):619-28.
28. Yoo BC, Park JW, Kim HJ, Lee DH, Cha YJ, Park SM. Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea. J Hepatol. 2003; 38(1):98-103.